APVO · ISSUER CIK 1671584
Aptevo Therapeutics Inc.
Between Aug 1, 2026 and Oct 29, 2026, 10 Aptevo Therapeutics Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗10 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 10, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 202621:39 | Aug 6, 2026 | APVO | Director | M · Exercise | — | +400 | 400 | New | — | ||
| Aug 10, 202621:38 | Aug 6, 2026 | APVO | President and CEO, Director | M · Exercise | — | +961 | 961 | New | — | ||
| Aug 10, 202621:37 | Aug 6, 2026 | APVO | SVP, CFO | M · Exercise | — | +638 | 638 | New | — | ||
| Aug 10, 202621:36 | Aug 6, 2026 | APVO | SVP, GC, BD & Corp Affairs | M · Exercise | — | +638 | 638 | New | — | ||
| Aug 10, 202621:35 | Aug 6, 2026 | APVO | SVP, CMO | M · Exercise | — | +638 | 638 | New | — | ||
| Aug 10, 202621:35 | Aug 6, 2026 | APVO | SVP, CMO | F · Tax | $4.07 | −156 | 482 | -24% | $634.92 | ||
| Aug 10, 202621:35 | Aug 6, 2026 | APVO | Director | M · Exercise | — | +400 | 1,150 | +53% | — | ||
| Aug 10, 202621:34 | Aug 6, 2026from Jul 17, 2026 | APVO | Executive Chair, Director | M · Exercise | — | +1,667 | 1,667 | New | — | ||
| Aug 10, 202621:34 | Aug 6, 2026 | APVO | Executive Chair, Director | F · Tax | $4.07 | −406 | 1,261 | -24% | $2K | ||
| Aug 10, 202621:33 | Aug 6, 2026 | APVO | Director | M · Exercise | — | +400 | 400 | New | — | ||
| Aug 10, 202621:32 | Aug 6, 2026 | APVO | Director | M · Exercise | — | +400 | 400 | New | — | ||
| Aug 10, 202621:30 | Aug 6, 2026 | APVO | Director | M · Exercise | — | +400 | 400 | New | — |